TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Edwards Lifesciences; Medtronic; 4C Medical
- Grant Support/Research Contract - Abbott Vascular; Edwards Lifesciences; Medtronic; Cardiolvalve; 4C Medical; Restore Medical; Cardiomech; INQB8
Video Player is loading.